Medical News

RSS

Early use of therapeutic anticoagulation does not improve survival of critically ill COVID-19 patients

Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.

3 Feb 2021

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.

3 Feb 2021

Latest clinical trial supports UK’s decision to delay second COVID vaccine dose

Researchers in the UK, South Africa and Brazil have reported the latest efficacy results from phase III trials of the Oxford–AstraZeneca vaccine currently being rolled out in the UK to protect against coronavirus disease 2019 (COVID-19).

3 Feb 2021

Dispelling vaccine misinformation and myths in California’s breadbasket

Dust swirled in the air as Luz Gallegos parked her SUV on the side of a dirt road. She had just learned that her aunt died of covid-19 — the third family member to succumb to the disease in only two weeks.

3 Feb 2021

Biomarkers could help discriminate cancer therapy-associated kidney injury from other causes

A study by Mayo Clinic researchers published in Kidney International Reports finds that immune checkpoint inhibitors, may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis. Immune checkpoint inhibitors are used to treat cancer by stimulating the immune system to attack cancerous cells.

3 Feb 2021

Viral load the main driver of SARS-CoV-2 transmission

A study conducted by researchers in the UK and Spain suggests that viral load is the main determinant of transmission risk in cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

3 Feb 2021

Experimental intranasal influenza vaccine produces durable immune response

An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal of Clinical Investigation.

3 Feb 2021

Major changes in life influence the amount of physical activity

Life changes influence the amount of physical activity in a person, according to a recent study by the University of Jyväskylä.

3 Feb 2021

Moffitt researchers reveal why some ovarian cancer patients evolve better than others

The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed.

3 Feb 2021

CU researchers awarded NEI's 3D ROC prize to accelerate development of new therapies

Natalia Vergara, PhD, assistant professor of ophthalmology at the University of Colorado School of Medicine, has been awarded a 3D ROC prize by the National Eye Institute for her research team's work to create better models to accelerate the development of new therapies for retinal diseases.

3 Feb 2021

Extreme blood sugar swings in patients with type 2 diabetes linked to high risk of heart disease

In patients with type 2 diabetes, big swings in blood sugar levels between doctors' visits are associated with an increased risk of heart disease.

3 Feb 2021

Novel personalized screening tool to better detect suicidal youths

The suicide rate among American adolescents has rose drastically over the last decade, but many at-risk youths aren't receiving the mental health services they need.

3 Feb 2021

Scalp cooling physically protects hair follicles from chemotherapy drugs, research shows

Ground-breaking research from the University of Huddersfield, announced ahead of World Cancer Day 2021, proves that scalp cooling physically protects hair follicles from chemotherapy drugs.

3 Feb 2021

Could rapid result low sensitivity SARS-CoV-2 tests improve pandemic quarantine strategies?

Researchers in the USA have re-examined current testing and quarantining regimens for SARS-CoV-2. They suggest that the RT-PCR method and 14-day isolation rule may not be the most effective approach in managing viral transmission.

3 Feb 2021

Tiny molecular motions are of key significance in modern anti-cancer drugs

Modern immunotherapeutic anti-cancer drugs support a natural mechanism of the immune system to inhibit the growth of cancer cells.

3 Feb 2021

Researchers engineer "Nanotraps" that block SARS-CoV-2 infection

Researchers at Chicago University have developed an innovative new anti-SARS-CoV-2 therapy called “Nanotraps” – a family of nano-enabled virus-trapping particles – which have shown positive results in vitro, in vivo, and in human ex vivo trials.

3 Feb 2021

People with severe mental disorders have higher risk of death from COVID-19

People with severe mental disorders have a significantly increased risk of dying from COVID-19. This has been shown in a new study from Umeå University and Karolinska Institutet in Sweden.

3 Feb 2021

Novel 3D-printed esophageal stents could revolutionize the delivery of cancer treatment

World-first 3D printed esophageal stents developed by the University of South Australia could revolutionize the delivery of chemotherapy drugs to provide more accurate, effective and personalized treatment for patients with esophageal cancer.

3 Feb 2021

In Austin, some try to address vaccine inequity, but a broad plan is elusive

Communities of color have been among the hardest hit during the pandemic. But advocates in Texas say those communities are likely to have a harder time getting the vaccine in the coming months, so they are urging local leaders to step in.

3 Feb 2021

100 million covid shots in 100 days doesn’t get us back to normal

April 30 will mark the end of the first 100 days of President Joe Biden's tenure. That's a benchmark presidents often set for making good on high-priority campaign promises.

3 Feb 2021

Medical News

Early use of therapeutic anticoagulation does not improve survival of critically ill COVID-19 patients

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

Latest clinical trial supports UK’s decision to delay second COVID vaccine dose

Dispelling vaccine misinformation and myths in California’s breadbasket

Biomarkers could help discriminate cancer therapy-associated kidney injury from other causes

Viral load the main driver of SARS-CoV-2 transmission

Experimental intranasal influenza vaccine produces durable immune response

Major changes in life influence the amount of physical activity

Moffitt researchers reveal why some ovarian cancer patients evolve better than others

CU researchers awarded NEI's 3D ROC prize to accelerate development of new therapies

Extreme blood sugar swings in patients with type 2 diabetes linked to high risk of heart disease

Novel personalized screening tool to better detect suicidal youths

Scalp cooling physically protects hair follicles from chemotherapy drugs, research shows

Could rapid result low sensitivity SARS-CoV-2 tests improve pandemic quarantine strategies?

Tiny molecular motions are of key significance in modern anti-cancer drugs

Researchers engineer "Nanotraps" that block SARS-CoV-2 infection

People with severe mental disorders have higher risk of death from COVID-19

Novel 3D-printed esophageal stents could revolutionize the delivery of cancer treatment

In Austin, some try to address vaccine inequity, but a broad plan is elusive

100 million covid shots in 100 days doesn’t get us back to normal

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News